• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌切除术:手术切缘和输血对长期生存的影响。对209例连续患者的分析。

Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients.

作者信息

Tralhão J G, Kayal S, Dagher I, Sanhueza M, Vons C, Franco D

机构信息

Service de Chirurgie Géndérale, H6pital Antoine Béclère, Facultd de Médecine Paris XI, France.

出版信息

Hepatogastroenterology. 2007 Jun;54(76):1200-6.

PMID:17629070
Abstract

BACKGROUND/AIMS: Certain prognostic factors affect the postoperative mortality and long-term survival of patients following hepatic resection for hepatocellular carcinoma (HCC) and may change the surgical strategy.

METHODOLOGY

209 consecutive patients underwent hepatic resection for HCC in our hospital. Seventy-three patients underwent major resection and 136 underwent minor resections. We looked for correlations between clinical, biological, surgical and pathological factors and postoperative mortality, disease-free survival and overall survival.

RESULTS

The postoperative mortality rate was 7.7% (it fell to 0% in the last two years). The cumulative overall five-year survival rate was 27% and the overall disease-free survival rate was 7.3%. Multivariate analysis identified: (1) two independent prognostic factors for postoperative mortality: age and tumor size; (2) one risk factor for tumor recurrence: intraoperative blood transfusion, and (3) three independent prognostic factors for overall survival: infiltrative tumor type, surgical margin <10 mm and intraoperative blood transfusion.

CONCLUSIONS

In addition to routine staging of the tumor, the preoperative evaluation of HCC patients should include tests to determine whether the tumor is infiltrative or expansive and whether it will be possible to obtain a surgical margin (>10 mm). This procedure should make it possible to propose an appropriate neoadjuvant treatment only to these patients. The prevention of intraoperative bleeding or blood transfusion should improve the disease-free and overall survival rates in HCC patients.

摘要

背景/目的:某些预后因素会影响肝细胞癌(HCC)肝切除术后患者的死亡率和长期生存率,并可能改变手术策略。

方法

我院209例连续接受HCC肝切除术的患者。73例行大手术切除,136例行小手术切除。我们探寻临床、生物学、手术和病理因素与术后死亡率、无病生存率和总生存率之间的相关性。

结果

术后死亡率为7.7%(最近两年降至0%)。累积总五年生存率为27%,总无病生存率为7.3%。多因素分析确定:(1)术后死亡的两个独立预后因素:年龄和肿瘤大小;(2)肿瘤复发的一个危险因素:术中输血,以及(3)总生存的三个独立预后因素:浸润性肿瘤类型、手术切缘<10mm和术中输血。

结论

除了常规的肿瘤分期外,HCC患者的术前评估应包括检测以确定肿瘤是浸润性还是膨胀性的,以及是否有可能获得手术切缘(>10mm)。这一程序应仅能为这些患者提出合适的新辅助治疗方案。预防术中出血或输血应能提高HCC患者的无病生存率和总生存率。

相似文献

1
Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients.肝细胞癌切除术:手术切缘和输血对长期生存的影响。对209例连续患者的分析。
Hepatogastroenterology. 2007 Jun;54(76):1200-6.
2
Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.小肝癌患者行肝段切除术或肝叶切除术:20 年经验回顾
Surgery. 2010 May;147(5):676-85. doi: 10.1016/j.surg.2009.10.043. Epub 2009 Dec 11.
3
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
4
Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.手术失血可独立预测肝细胞癌切除术后的复发和生存情况。
Ann Surg. 2009 Apr;249(4):617-23. doi: 10.1097/SLA.0b013e31819ed22f.
5
Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study.接受术中异体输血的肝细胞癌患者的预后及术后淋巴细胞计数:一项回顾性研究。
Eur J Surg Oncol. 2008 Mar;34(3):339-45. doi: 10.1016/j.ejso.2007.02.010. Epub 2007 Apr 2.
6
[Impact of surgical operation-related factors on long-term survival of patients with hepatocellular carcinoma after hepatectomy].[手术相关因素对肝癌肝切除术后患者长期生存的影响]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):386-92.
7
Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients.肝细胞癌肝切除术后的长期预后:204例连续患者的生存分析
Cancer. 1998 Dec 1;83(11):2302-11.
8
Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients.肝硬化患者肝细胞癌的保守性肝切除术
Int Surg. 1996 Jul-Sep;81(3):280-3.
9
Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.孤立性大肝细胞癌:一种肝切除术后预后良好的肝细胞癌特殊亚型。
Ann Surg. 2009 Jan;249(1):118-23. doi: 10.1097/SLA.0b013e3181904988.
10
Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma.肝细胞癌根治性肝切除术后围手术期输血与生存情况
Hepatogastroenterology. 2005 Mar-Apr;52(62):524-9.

引用本文的文献

1
Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.肝切除术治疗单发肝细胞癌:切缘宽度不预测生存。
J Gastrointest Surg. 2021 Jul;25(7):1727-1735. doi: 10.1007/s11605-020-04765-6. Epub 2020 Aug 10.
2
Fluorine-18 Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma: Correlation with Glucose Transporters and p53 Expression.氟-18氟脱氧葡萄糖在肝细胞癌中的摄取:与葡萄糖转运蛋白及p53表达的相关性
J Clin Exp Hepatol. 2015 Sep;5(3):183-9. doi: 10.1016/j.jceh.2015.05.003. Epub 2015 Jun 3.
3
Relationship of different surgical margins with recurrence-free survival in patients with hepatocellular carcinoma.
肝细胞癌患者不同手术切缘与无复发生存率的关系。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3404-9. eCollection 2015.
4
Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk.代谢紊乱、非酒精性脂肪性肝病与肝大部切除术:围手术期被低估的风险。
J Gastrointest Surg. 2012 Dec;16(12):2247-55. doi: 10.1007/s11605-012-2044-x. Epub 2012 Oct 9.
5
Choice of approach for hepatectomy for hepatocellular carcinoma located in the caudate lobe: isolated or combined lobectomy?肝尾状叶肝细胞癌切除术式的选择:单独肝尾状叶切除还是联合肝叶切除?
World J Gastroenterol. 2012 Aug 7;18(29):3904-9. doi: 10.3748/wjg.v18.i29.3904.
6
Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma.促转移肿瘤抗原 1 在乙型肝炎病毒相关性肝细胞癌中过表达的相关因素。
Dig Dis Sci. 2012 Nov;57(11):2917-23. doi: 10.1007/s10620-012-2296-z. Epub 2012 Jul 10.
7
Lessons learned from 100 initial cases of laparoscopic liver surgery.从100例腹腔镜肝脏手术的初始病例中吸取的经验教训。
J Korean Surg Soc. 2011 May;80(5):334-41. doi: 10.4174/jkss.2011.80.5.334. Epub 2011 May 6.
8
Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era.在现代,肝切除术治疗后丙型肝炎病毒抗体阳性的肝细胞癌患者的长期预后得到改善。
World J Surg. 2011 May;35(5):1072-84. doi: 10.1007/s00268-011-1013-y.
9
Surgical treatment of huge hepatocellular carcinoma in the caudate lobe.尾状叶巨大肝细胞癌的外科治疗。
Surg Today. 2011 Apr;41(4):520-5. doi: 10.1007/s00595-009-4313-1. Epub 2011 Mar 23.
10
Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma.术后发病率导致肝门部胆管癌切除术后长期生存率降低。
HPB (Oxford). 2011 Feb;13(2):139-47. doi: 10.1111/j.1477-2574.2010.00262.x. Epub 2010 Dec 7.